Conference Information

Welcome Message

Welcome to a Global Platform for Scientific Innovation and Healthcare Advancement!

On behalf of the Organizing Committee, it is our distinct pleasure to welcome you to the 11^th International Conference on Virology, Influenza, and Infectious Diseases, taking place from November 16–17, 2026, in London, UK.

Our guiding theme this year, "Where Pathogens Meet Progress: Advancing Therapeutics, Vaccines, and Diagnostics," captures the core mission of our gathering. We are providing a vital global platform to explore cutting-edge advancements across virology , microbiology, genomics , and clinical therapeutics.

Over these two inspiring days at Virology 2026 , you will have the opportunity to engage in keynote sessions, interactive workshops, and strategic networking events designed to exchange critical knowledge, share pioneering research, and build lasting international collaborations across Virology, Influenza , Infectious Diseases, Vaccines , and Pathogenesis, driving innovation and advancing global healthcare.

Thank you for bringing your unique expertise and dedication to this vital global forum at Virology 2026. We look forward to welcoming you in person to London and creating meaningful collaborations that shape the future of healthcare.

Warm Regards,
Stella Joseph
Program Manager | Virology 2026

About Conference

Overview of the Conference

Join Virology 2026 on November 16–17, 2026, in London, UK, and connect with leading researchers, healthcare professionals, academicians, clinicians, and industry experts from around the world.

This global conference is designed to showcase the latest advancements in virology, influenza, infectious diseases, vaccines, microbiology, genomics, diagnostics, therapeutics, and modern healthcare innovations.

Conference Focus Areas

Virology 2026 highlights important developments across biomedical science and healthcare, including:

Advances in Virology and Viral Research
Influenza and Emerging Infectious Diseases
Bacterial Infections and Disease Mechanisms
Vaccine Development and Immunization Strategies
Antibiotic Research and Resistance Studies
Virus Detection and Clinical Applications
HIV Research and Therapeutic Innovations
COVID and Global Health Preparedness

The Virology 2026 conference program includes keynote presentations, scientific sessions, workshops, poster presentations, panel discussions, and networking opportunities.

Event Style & Engagement

The conference offers an engaging international platform for both in-person and virtual participation at Virology 2026, enabling attendees worldwide to connect, collaborate, and exchange scientific knowledge across Virology, Influenza, Infectious Diseases, and Vaccines.

Participants will gain access to expert presentations, scientific discussions, and educational resources covering Genetics, Immunization, Virus Research, and emerging advancements that support academic and professional growth.

Educational Takeaways

Understand recent advancements in virology and infectious diseases research
Explore innovative diagnostic tools and therapeutic approaches
Discuss strategies for infection prevention and global healthcare improvement
Learn from scientific case studies and clinical experiences
Discover emerging technologies transforming biomedical science and healthcare

Reasons to Participate

Connect with internationally recognized experts and researchers
Present and discuss innovative scientific research
Expand global academic and professional collaborations
Explore current healthcare trends and scientific technologies
Enhance knowledge, networking, and career development opportunities

Call for Abstract

Be part of Virology 2026 and showcase your research to a global scientific community. We welcome submissions from researchers, clinicians, academicians, healthcare professionals, scientists, and industry leaders who are passionate about advancing virology and infectious disease research.

Presentation Categories

Oral Presentation: Present your research and share your findings with conference participants.

Poster Presentation: Display your research in a poster format and discuss your work with attendees.

E-Poster Presentation: Present your research digitally through an electronic poster and reach a wider audience.

Scientific Sessions

Before submitting your abstract, please visit the Call for Abstracts section to review and select the most appropriate abstract track title for your submission.

Abstract Guidelines

Please visit our conference website to download the official Abstract Template and prepare your submission accordingly.

How to Submit Your Abstract

You may submit your abstract through either of the following methods:

1. Online Submission Portal

Submit your abstract through the official conference submission portal. Select the scientific session that best aligns with your research topic and ensure all required information is included before submission.

To submit your abstract, please visit the Virology 2026 Conference website.

2. Email Submission

Authors may also submit their abstracts directly via email virology@alliedgathering.com to the conference organizing committee.

Review and Acceptance Process

All submitted abstracts will undergo evaluation by the Scientific Committee based on scientific quality, relevance, and originality. Authors of accepted abstracts will receive an official Abstract Acceptance Letter within 24–48 hours of review completion, along with registration information and further participation guidelines.

Scientific Sessions

Session 1: Virology

This session at Virology 2026 focuses on the latest advancements, scientific discoveries, and emerging technologies shaping modern Virology and infectious disease research. Key topics include viral structure, replication mechanisms, host–virus interactions, clinical diagnostics, antiviral therapies, vaccine development, and innovative approaches supporting global public health and disease prevention.

Session Tracks

1.1 Viral Structure & Classification
1.2 Replication & Pathogenesis
1.3 Clinical Virology
1.4 Antiviral Therapies

Join global experts to explore the future of Virology and innovative solutions for global health at Virology 2026.

Related Conference

Related Associations and Societies

Session 2: Influenza Research

This session at Virology 2026 highlights current developments and research progress in influenza prevention, disease monitoring, and therapeutic advancement. The session emphasizes innovative vaccination approaches, epidemiological studies, antiviral interventions, and surveillance strategies designed to strengthen outbreak preparedness and support effective public health responses against seasonal and emerging influenza threats.

Session Tracks

2.1 Universal Influenza Vaccines
2.2 Influenza Epidemiology
2.3 Antiviral Therapies
2.4 Pandemic Preparedness
2.5 Surveillance & Prevention

Connect with leading researchers to explore scientific progress and emerging perspectives in Influenza Research at Virology 2026.

Related Conferences

Related Journals

Session 3: Infectious Diseases

At Virology 2026, this session focuses on the latest developments, emerging challenges, and innovative approaches in Infectious Diseases and global healthcare. It highlights the prevention, diagnosis, treatment, and management of diseases caused by viruses, bacteria, fungi, and parasites affecting populations worldwide.

Attendees will gain insights into advanced diagnostic technologies, modern therapeutic strategies, vaccine innovations, and public health initiatives designed to improve disease control and patient outcomes.

Session Tracks

3.1 Emerging infectious diseases
3.2 Infectious disease diagnostics
3.3 Vaccine and prevention strategies
3.4 Infection control and management

The session promotes international collaboration to strengthen healthcare systems and address current and future infectious disease challenges.

Related Conference

Related Associations and Societies

Session 4: Vaccine Development

As part of Virology 2026, this session examines the expanding role of vaccine science in preventing and controlling infectious and emerging viral diseases. Discussions will highlight advances in vaccine platforms, immune activation mechanisms, formulation technologies, translational research, and innovative delivery systems designed to enhance vaccine effectiveness and accessibility across diverse populations. The session will also address emerging directions in preventive and therapeutic immunization strategies.

Session Tracks

4.1 Novel Vaccine Platforms
4.2 mRNA & Genetic Vaccines
4.3 Viral Vector-Based Vaccines
4.4 Vaccine Immunology

Participate in insightful discussions and explore pioneering discoveries advancing modern viral science at Virology 2026.

Related Conferences

Related Journals

Session 5: Viral Genetics

As part of Virology 2026, this session explores the genetic foundations of viruses and their role in viral evolution, transmission, adaptation, and disease progression. Discussions will cover advances in viral genomics, mutation analysis, genome organization, genetic diversity, and molecular processes influencing viral behavior. The session also highlights emerging technologies supporting genomic surveillance, precision diagnostics, and the development of future therapeutic approaches.

Session Tracks

5.1 Viral Genome Structure
5.2 Genetic Variation & Mutation
5.3 Viral Evolution & Adaptation
5.4 Molecular Virology

Join global experts to discover emerging insights and innovations shaping the future of Viral Genetics at Virology 2026.

Related Conference

Related Associations and Societies

Session 6: Pathogen Biology

This session at Virology 2026 focuses on understanding the biological characteristics, evolution, and disease mechanisms of pathogens affecting global health. Attendees will gain insights into host–pathogen interactions, microbial adaptation, infection pathways, and emerging technologies supporting diagnostics, prevention, and therapeutic development. Special attention will be given to viral and bacterial diseases influencing public health and immunization strategies worldwide.

Session Tracks

6.1 Pathogen Structure & Function
6.2 Viral & Bacterial Biology
6.3 Infection Mechanisms
6.4 Host–Pathogen Interactions
6.5 Molecular Pathogenesis

Participate in insightful discussions and explore pioneering discoveries advancing modern viral science at Virology 2026.

Related Conferences

Related Journals

Session 7: Antibiotic Resistance

This scientific session highlights the growing challenge of antibiotic resistance and its impact on global healthcare and infectious disease management at Virology 2026. Discussions will focus on resistance mechanisms, microbial adaptation, antimicrobial stewardship, diagnostic advancements, and therapeutic approaches developed to combat drug-resistant infections and improve treatment outcomes. The session also emphasizes collaborative strategies that support sustainable infection control and strengthen public health preparedness.

Session Tracks

7.1 Mechanisms of Antibiotic Resistance
7.2 Antimicrobial Resistance (AMR)
7.3 Resistant Bacterial Pathogens
7.4 Molecular Diagnostics

Join global experts to discuss innovative solutions and future strategies addressing Antibiotic Resistance at Virology 2026.

Related Conference

Related Associations and Societies

Session 8: Immune Responses

This scientific track presents current perspectives on immune responses and their role in recognizing and controlling viral and infectious diseases at Virology 2026. Attendees will gain insights into immune regulation, cellular defense systems, inflammatory pathways, and advances in immunological research supporting disease prevention, therapeutic innovation, and long-term protection against emerging health challenges.

Session Tracks

8.1 Innate Immune Mechanisms
8.2 Adaptive Immunity
8.3 Cellular Immune Responses
8.4 Immune Signaling Pathways

Discover cutting-edge developments and connect with experts shaping the future of viral and biomedical research at Virology 2026.

Related Conferences

Related Journals

Session 9: Emerging Viruses

This track explores current advancements in understanding newly identified and rapidly evolving viruses that pose challenges to global health systems at Virology 2026. Discussions will address viral emergence, cross-species transmission, outbreak investigation, genomic monitoring, and innovative response strategies aimed at improving early detection and strengthening preparedness against future viral threats. The session highlights scientific progress in understanding evolving pathogens and their public health impact.

Session Tracks

9.1 Emerging Viral Pathogens
9.2 Zoonotic Virus Transmission
9.3 Viral Evolution & Adaptation
9.4 Outbreak Investigation

Explore breakthrough technologies and scientific progress redefining the landscape of virology and public health at Virology 2026.

Related Conference

Related Associations and Societies

Session 10: HIV Research

This program highlights recent advances and transformative research in understanding Human Immunodeficiency Virus (HIV) and its impact on global infectious disease management at Virology 2026. Key topics include viral mechanisms, infection pathways, immune interactions, novel therapeutic approaches, and emerging prevention strategies. The session also emphasizes developments in HIV diagnostics, treatment outcomes, and vaccine research supporting advancements in healthcare.

Session Tracks

10.1 HIV Molecular Biology
10.2 Viral Transmission & Infection
10.3 Host Immune Interactions
10.4 Antiretroviral Therapeutics

Join global experts to explore emerging discoveries and next-generation innovations shaping the future of HIV Research at Virology 2026.

Related Conferences

Related Journals

Session 11: COVID Studies

This scientific session presents recent progress and emerging developments in coronavirus research, disease transmission, and outbreak control strategies at Virology 2026. Attendees will gain insights into emerging surveillance methods, advanced diagnostic platforms, immune response profiling, COVID-related infection monitoring, therapeutic innovations, and public health initiatives developed to improve preparedness against future infectious threats.

The session also addresses post-viral health effects, infectious disease management, and evolving preventive approaches supporting resilient healthcare systems.

Session Tracks

11.1 Coronavirus Biology & Evolution
11.2 Transmission Dynamics
11.3 Diagnostic Innovations
11.4 Immune Response Mechanisms

Be part of global conversations advancing scientific excellence and next-generation discoveries in Virology at Virology 2026.

Related Conference

Related Associations and Societies

Session 12: Cytokine Signalling

This global research session presents current advances in cytokine-mediated communication pathways that regulate immune responses, inflammatory mechanisms, and host defense systems at Virology 2026.

The session highlights advances in immune modulation, cellular signaling, and translational research supporting therapeutic innovation and infectious disease management.

Session Tracks

12.1 Cytokine Biology
12.2 Cell Signaling Networks
12.3 Inflammatory Responses
12.4 Host Defense Mechanisms

Engage with global scientific leaders and uncover emerging trends driving the next generation of virology research at Virology 2026.

Related Conferences

Related Journals

Session 13: Viral Pathogenesis

This session at Virology 2026 focuses on the mechanisms through which viruses establish infection, adapt within host systems, and influence disease progression. The session emphasizes advances in pathogenic processes, infection biology, and innovative strategies supporting prevention and therapeutic development.

Session Tracks

13.1 Mechanisms of Viral Infection
13.2 Viral Entry Pathways
13.3 Host–Virus Interactions
13.4 Disease Progression

Join international experts to exchange ideas and explore innovative advancements transforming infectious disease research at Virology 2026.

Related Conference

Related Associations and Societies

Session 14: Molecular Virology

This session at Virology 2026 focuses on molecular mechanisms governing viral genetics, replication, and cellular interactions. The session highlights advanced technologies and emerging discoveries supporting precision diagnostics, disease surveillance, and next-generation virology research.

Session Tracks

14.1 Viral Genetics
14.2 Molecular Interactions
14.3 Viral Replication
14.4 Genomic Technologies

Connect with leading researchers and discover the latest scientific breakthroughs shaping the future of Virology at Virology 2026.

Related Conferences

Related Journals

Session 15: Viral Epidemiology

This session at Virology 2026 focuses on the distribution, transmission patterns, and population-level impact of viral diseases across global communities. The session highlights advances in outbreak analytics, surveillance systems, risk assessment, and epidemiological research supporting effective disease prevention and public health decision-making.

Session Tracks

15.1 Viral Transmission Dynamics
15.2 Disease Surveillance
15.3 Epidemiological Modeling
15.4 Outbreak Investigation

Connect with leading experts to discover emerging insights and innovative approaches shaping the future of Viral Epidemiology at Virology 2026.

Related Conference

Related Associations and Societies

Session 16: Antiviral Therapies

This research-focused session examines advanced therapeutic approaches for preventing and controlling viral infections at Virology 2026. Discussions will highlight progress in antiviral agents, precision medicine, therapeutic target discovery, and translational research designed to improve treatment effectiveness and strengthen infectious disease management worldwide.

Session Tracks

16.1 Antiviral Drug Discovery
16.2 Therapeutic Target Identification
16.3 Precision Antiviral Medicine
16.4 Novel Drug Delivery Systems

Join scientific leaders to explore breakthrough discoveries and transformative developments advancing Antiviral Therapies at Virology 2026.

Related Conferences

Related Journals

Session 17: Immunization Strategies

As part of Virology 2026, focuses on modern immunization approaches supporting disease prevention and long-term population health. The session highlights developments in vaccine implementation, immune protection strategies, policy frameworks, and innovative methods that improve global immunization outcomes and healthcare resilience.

Session Tracks

17.1 Preventive Immunization Programs
17.2 Vaccine Implementation
17.3 Immune Protection Mechanisms
17.4 Public Health Vaccination

Join global researchers and healthcare professionals to explore innovative strategies and future directions in Immunization at Virology 2026.

Related Conference

Related Associations and Societies

Session 18: Diagnostic Virology

This interactive session explores advanced diagnostic approaches used to identify, monitor, and characterize viral infections at Virology 2026. The session highlights innovations in laboratory technologies, molecular detection systems, rapid testing platforms, and precision diagnostics supporting early intervention and improved clinical outcomes.

Session Tracks

18.1 Molecular Viral Diagnostics
18.2 Clinical Virology Testing
18.3 Rapid Detection Technologies
18.4 Biomarker Identification
18.5 Point-of-Care Diagnostics

Be part of global conversations advancing scientific excellence and next-generation discoveries in Virology at Virology 2026.

Related Conferences

Related Journals

Session 19: Zoonotic Infections

This conference session focuses on infectious disease research and emerging approaches supporting disease prevention, diagnosis, and clinical management at Virology 2026. The session highlights advances in pathogen monitoring, transmission research, surveillance systems, and prevention strategies designed to reduce emerging infectious threats.

Session Tracks

19.1 Animal-to-Human Transmission
19.2 Emerging Zoonotic Diseases
19.3 Cross-Species Infection
19.4 Pathogen Surveillance

Connect with leading researchers to discover innovative approaches and future perspectives shaping Zoonotic Infection research at Virology 2026.

Related Conference

Related Associations and Societies

Session 20: Precision Medicine

As part of Virology 2026, focuses on personalized healthcare approaches that integrate molecular insights, targeted therapies, and predictive technologies for improved disease management. The session highlights advances in individualized treatment strategies, precision diagnostics, and translational medicine supporting better patient outcomes and healthcare innovation.

Session Tracks

20.1 Personalized Therapeutics
20.2 Precision Diagnostics
20.3 Biomarker Research
20.4 Genomic Medicine
20.5 Targeted Treatment Strategies

Join international experts to explore transformative discoveries and innovative solutions shaping the future of Precision Medicine at Virology 2026.

Related Conferences

Related Journals

Session 21: Microbial Innovations

This session at Virology 2026 focuses on emerging innovations transforming microbial science and infectious disease research. The session highlights advances in microbial technologies, novel therapeutic approaches, bioengineering applications, Bacterial research, and scientific developments supporting improved healthcare solutions and disease prevention strategies.

Session Tracks

21.1 Microbial Biotechnology
21.2 Innovative Therapeutic Systems
21.3 Applied Microbial Research
21.4 Bioengineering Approaches

Join scientific leaders to explore breakthrough discoveries and next-generation innovations advancing Microbial Innovations at Virology 2026.

Related Conference

Related Associations and Societies

Session 22: Genomic Medicine

This session at Virology 2026 focuses on the integration of genomic science into modern healthcare for improved disease understanding and personalized treatment approaches. The session highlights advances in genomic technologies, molecular profiling, precision healthcare, and innovative clinical applications supporting future medical transformation.

Session Tracks

22.1 Clinical Genomics
22.2 Molecular Profiling
22.3 Personalized Healthcare
22.4 Genomic Diagnostics

Connect with leading scientists and gain insights into transformative research influencing future healthcare and virological advancements at Virology 2026

Related Conferences

Related Journals

Session 23: Global Healthcare

As part of Virology 2026, focuses on advancing healthcare systems through collaborative research, disease prevention strategies, and innovative public health initiatives. The session highlights developments in healthcare accessibility, global preparedness, healthcare technologies, genetic research, bacterial infection studies, and integrated approaches designed to improve worldwide health outcomes.

Session Tracks

23.1 Global Health Systems
23.2 Public Health Innovation
23.3 Healthcare Accessibility
23.4 Disease Prevention Strategies
23.5 Digital Health Solutions

Be part of global conversations advancing scientific excellence and next-generation discoveries in Virology at Virology 2026.

Related Conference

Related Associations and Societies

Market Analysis

Infectious Disease Diagnostics Market Analysis
Market Projections & Growth Verticals

Market Segment	Current/Base Value	Projected Value	CAGR	Key Growth Drivers
Infectious Disease Diagnostics	$26.99 Billion.	$42.2 Billion (by 2030)	9.7%	Early disease detection, pandemic preparedness, personalized healthcare.
Viral Disease Diagnosis	$55 Billion	$140 Billion (by 2034)	7.3% to 9.8%	Rising prevalence of HIV, Hepatitis, and respiratory viruses.
Virology Testing	$4.1 – $7 Billion	$15.2 Billion (by 2030)	5.8% to 8.2%	Rapid adoption of self-testing kits and automated lab systems.
Influenza Diagnostics	Sub-Billion	$2.5 to 3.3 Billion (by 2032–2034)	7.7%	Seasonal outbreaks, multiplex respiratory panels, combined Flu/COVID testing.

The Infectious Disease Diagnostics market continues to expand due to the rising demand for rapid disease detection, outbreak monitoring, and advanced diagnostic solutions. Market growth is supported by increasing healthcare investments and global preparedness initiatives.

Viral Disease Diagnosis remains a major growth segment, driven by the increasing prevalence of HIV, influenza, and other viral infections. Advances in molecular testing, self-testing technologies, AI-powered diagnostics, and respiratory disease monitoring are accelerating innovation and creating new opportunities across the diagnostics industry.

Major Market Drivers

Point-of-Care Testing (POCT)

Importance
POCT is transforming diagnostics by enabling rapid detection of Infectious Diseases, Influenza, COVID, and other Virus-related conditions directly near the patient without requiring centralized laboratory infrastructure.

Benefits

Faster clinical decisions
Reduced healthcare costs
Improved accessibility in rural regions
Increased patient convenience

Market Impact
POCT continues to emerge as one of the most influential healthcare segments by supporting early diagnosis, improving Immunization programs, and strengthening disease management strategies across modern Virology and public health systems.

Artificial Intelligence & Advanced Technologies

Advanced technologies including Artificial Intelligence (AI), Machine Learning (ML), Next-Generation Sequencing (NGS), and CRISPR are revolutionizing Virology, Genetics, and Infectious Diseases research. These innovations enable rapid pathogen identification, improve understanding of Pathogenesis, support monitoring of HIV and Flu, reduce testing time and costs, and strengthen outbreak surveillance and healthcare decision-making.

Leading Industry Players

Abbott Laboratories: Pioneering rapid testing and diagnostic innovation.
Thermo Fisher Scientific: Advancing molecular diagnostics and sequencing technologies.
Becton, Dickinson and Company (BD): Supporting automated screening and laboratory
solutions.

11th International Conference on
Virology, Influenza, and Infectious Diseases

Quick Links

Theme: Where Pathogens Meet Progress: Advancing Therapeutics, Vaccines, and Diagnostics

Conference Information

Welcome Message

About Conference

Call for Abstract

Scientific Sessions

Market Analysis